JP Morgan Chase
TELO icon

JP Morgan Chase’s Telomir Pharmaceuticals TELO Stock Holding History

JP Morgan Chase’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151 Hold
121
– – ﹤0.01% 7516
2026
Q1 		$138 Hold
121
– – ﹤0.01% 7288
2025
Q4 		$161 Buy
+121
New +$175 ﹤0.01% 7185
2025
Q3 		– Sell
-1,762
Closed -$2.2K – 7771
2025
Q2 		$2.2K Sell
1,762
-7,519
-81% -$17.4K ﹤0.01% 6526
2025
Q1 		$30K Sell
9,281
-32,163
-78% -$141K ﹤0.01% 6033
2024
Q4 		$171K Buy
41,444
+37,980
+1,096% +$179K ﹤0.01% 5547
2024
Q3 		$22.2K Buy
3,464
+1,414
+69% +$6.89K ﹤0.01% 6216
2024
Q2 		$9.86K Sell
2,050
-555
-21% -$3.46K ﹤0.01% 6268
2024
Q1 		$13.6K Buy
+2,605
New +$19.7K ﹤0.01% 6298

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return

JP Morgan Chase's TELO Position: Q2 2026 in Review

JP Morgan Chase held its Telomir Pharmaceuticals (TELO) position steady in Q2 2026 at 121 shares worth $151. The position accounts for ﹤0.01% of the portfolio, ranked #7516.

JP Morgan Chase first reported a position in TELO in Q1 2024 and has held it in 9 quarters since. The position peaked at $171K in Q4 2024. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • JP Morgan Chase held 121 shares of Telomir Pharmaceuticals worth $151 as of Q2 2026.
  • JP Morgan Chase left its Telomir Pharmaceuticals share count unchanged in Q2 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7516 holding.
  • JP Morgan Chase first reported a position in Telomir Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • JP Morgan Chase's Telomir Pharmaceuticals position peaked at $171K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.